Data Mining at the FDA
The FDA has recommended the use of data mining to the drug industry, and their new Data Mining at FDA white paper summarizes their past and current data mining activities, and addresses data miners in all sectors.
Oracle Health Sciences’ Dr. Sameer Thapar, Director, Global Pharmacovigilance has studied this paper and offers highlights in a new Oracle Brief. Download it now to learn how the FDA uses:
- Oracle Health Sciences Empirica Study to analyze drug clinical trial data in either New Drug Applications or supplemental applications
- Oracle Health Sciences Empirica Signal for routine mining of drugs, foods, cosmetics, and dietary supplements
